Red Blood Cells



Indications and Reactions:

Role Indications Reactions
Primary
Anaemia 17.9%
Haemoglobin Decreased 12.8%
Aortic Aneurysm Repair 10.3%
Product Used For Unknown Indication 10.3%
Transfusion-related Acute Lung Injury 7.7%
Blood Product Transfusion 5.1%
Haemorrhage 5.1%
Ruptured Ectopic Pregnancy 5.1%
Haematocrit Decreased 2.6%
Haemorrhagic Anaemia 2.6%
Hip Surgery 2.6%
Hypopharyngeal Cancer 2.6%
Operative Haemorrhage 2.6%
Pharyngeal Cancer Stage Unspecified 2.6%
Road Traffic Accident 2.6%
Transfusion 2.6%
Upper Gastrointestinal Haemorrhage 2.6%
Urosepsis 2.6%
Transfusion-related Acute Lung Injury 31.9%
Transfusion Reaction 14.9%
Laboratory Test Abnormal 6.4%
Wheezing 6.4%
Product Quality Issue 4.3%
Transfusion-transmitted Infectious Disease 4.3%
Vomiting 4.3%
Circumstance Or Information Capable Of Leading To Medication Error 2.1%
Hyperhidrosis 2.1%
Hypoxia 2.1%
Intercepted Drug Dispensing Error 2.1%
Medication Error 2.1%
Respiratory Failure 2.1%
Resuscitation 2.1%
Sepsis 2.1%
Shock 2.1%
Skin Lesion 2.1%
Transfusion 2.1%
Unevaluable Event 2.1%
Urticaria 2.1%
Secondary
Drug Use For Unknown Indication 20.2%
Drug Therapy 8.9%
Shock Haemorrhagic 7.4%
Product Used For Unknown Indication 6.8%
Nutritional Support 6.4%
Pancytopenia 6.0%
Haemorrhagic Disorder 5.1%
Sedation 4.7%
Pain 4.0%
Cardiac Failure 3.4%
Fluid Replacement 3.4%
Intraoperative Care 3.4%
Thrombosis Prophylaxis 3.2%
Prophylaxis Against Gastrointestinal Ulcer 3.0%
Aortic Aneurysm Repair 2.6%
Infection 2.6%
Blood Product Transfusion 2.3%
Operative Haemorrhage 2.3%
Restlessness 2.3%
Allogenic Bone Marrow Transplantation Therapy 1.9%
Renal Failure Acute 25.0%
Transfusion-related Acute Lung Injury 13.6%
Transmission Of An Infectious Agent Via A Medicinal Product 11.4%
Hepatitis C 8.0%
Hepatitis B Surface Antigen Positive 5.7%
Thermal Burn 4.5%
Toxic Epidermal Necrolysis 4.5%
Htlv-1 Test Positive 3.4%
Toothache 3.4%
Transfusion Reaction 3.4%
Hepatitis B 2.3%
Hepatitis C Virus 2.3%
Hepatitis Post Transfusion 2.3%
Multi-organ Failure 2.3%
Transfusion-related Circulatory Overload 2.3%
Abdominal Pain 1.1%
Anaemia 1.1%
Anti-hbs Antibody Positive 1.1%
Anxiety 1.1%
Haemoglobin Decreased 1.1%
Concomitant
Product Used For Unknown Indication 33.3%
Drug Use For Unknown Indication 14.1%
Prophylaxis 8.2%
Coronary Artery Bypass 7.1%
Multiple Myeloma 5.3%
Pain 3.5%
Anaemia 3.2%
Hypertension 3.1%
Myelodysplastic Syndrome 3.0%
Premedication 2.6%
Aortic Valve Replacement 2.3%
Infection Prophylaxis 2.2%
Catheterisation Cardiac 1.9%
Nausea 1.9%
Constipation 1.6%
Anxiety 1.4%
Aplastic Anaemia 1.4%
Prophylaxis Against Graft Versus Host Disease 1.4%
Iron Overload 1.3%
Nuclear Magnetic Resonance Imaging 1.3%
Injury 11.3%
Pain 10.2%
Unevaluable Event 8.1%
Fear 6.8%
Anhedonia 6.3%
Renal Failure 5.9%
White Blood Cell Count Decreased 5.8%
Thrombocytopenia 5.3%
Anxiety 4.7%
Renal Impairment 4.5%
Sepsis 4.0%
Emotional Distress 3.8%
Stress 3.7%
Pneumonia 3.0%
Depression 3.0%
Renal Failure Acute 2.9%
Multi-organ Failure 2.9%
Death 2.8%
Pyrexia 2.7%
Weight Decreased 2.3%
Interacting
Drug Use For Unknown Indication 76.5%
Febrile Neutropenia 5.9%
Fungal Infection 5.9%
Haemorrhage 5.9%
Pain 5.9%
Pulmonary Oedema 50.0%
Urticaria 50.0%